Vaxart

$7.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.71 (+11.17%) Today

-$0.12 (-1.62%) As of 10:38 PM UTC after-hours

Why Robinhood?

You can buy or sell Vaxart and other stocks, options, and ETFs commission-free!

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA. The listed name for VXRT is Vaxart, Inc Common Stock.

CEO

Andrei Floroiu

Employees

Headquarters

South San Francisco, California

Founded

2004

Market Cap

778.87M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

19.35M

High Today

$7.13

Low Today

$6.01

Open Price

$6.61

Volume

12.76M

52 Week High

$17.49

52 Week Low

$0.266

Collections

VXRT Earnings

-$0.39

-$0.26

-$0.13

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

— per share

Actual

-$0.08 per share